By Samir S. Patel:
I am an LCA-Vision (LCAV) shareholder. After reviewing the details of the proposed transaction, I have concluded that the PhotoMedex (PHMD) offer materially undervalues the company. Thus, I am led to believe that...
PhotoMedex, Inc. (PHMD)
LCA Vision Acquisition Call
February 14, 2014 8:30 AM ET
Kim Golodetz – IR
Dolev Rafaeli – CEO
Dennis McGrath – President and CFO
Mike Celebrezze – CEO
E. Monteverde, a partner at Faruqi
& Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of LCA-Vision,
Inc. (“LCA-Vision” or the...
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) and LCA-Vision, Inc.
(NasdaqGS: LCAV)today announced the signing of a definitive
agreement pursuant to which PhotoMedex will acquire LCA-Vision for $5.37
per share in cash, or...
NEW YORK, NY -- (Marketwired) -- 01/06/14 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased PhotoMedex,...
Oramed Pharmaceuticals (NASDAQ: ORMP) shares moved up 15.68% to $17.85. The volume of Oramed Pharmaceuticals shares traded was 971% higher than normal. Oramed received patent allowance in Israel, Australia for platform technology in oral delivery...
PhotoMedex, Inc. (NASDAQ: PHMD) (TASE: PHMD) today announced that
it expects revenues for the fourth quarter of 2013 to be more than $60
million without any contribution from Japan, compared with prior
guidance issued on...
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to
determine whether PhotoMedex, Inc. (“PhotoMedex” or the “Company”) and
certain of its officers and directors made false and misleading
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.